$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018
Lloyd Price
JULY 5, 2018
billion to acquire Bioverativ, the Biogen spinout focused on developing treatments for hemophilia. As BioSpace noted when the deal was announced, Takeda will also take on a significant amount of debt through the deal, sending the price tag closer to $80 billion when that amount is included. France-based Sanofi plunked down $11.6
40 
Let's personalize your content